advanced disease / osteonecrosis / ocular inflammation / scleritis / common disease / influenza-like illness / headache / chronic pain / esophagitis / active GI disease receiving risedronate / GI disorders / inflammatory eye disease / nausea / conjunctivitis / Atrial fibrillation AF / upper GI disorders / deformity / metastatic bone disease / iritis / diarrhea / esophageal cancer / upper GI disease / Bone resorption / Paget disease / episcleritis / oral iBandronate Osteoporosis / acute renal injury / cancer / arthralgia / chills / esophageal irritation / muscle pain / upper abdominal pain / postmenopausal osteoporosis / bone metastases / pain / vomiting / renal insufficiency / Paget’s disease / III Osteoporosis Treatment Study23 / hypercalcemia / osteoporosis / Atrial fibrillation / adynamic bone disease / Inflammation / acute renal failure / uveitis / /
MedicalTreatment
oral therapy / /
Organization
Nuffield Orthopaedic Centre / MRC Epidemiology Resource Centre / Sheffield University Medical School / Department of Human Metabolism / Nuffield Department of Orthopaedics / Rheumatology and Musculoskeletal Diseases / Southampton General Hospital / Botnar Research Centre / European Medicines Agency / Dosing IntraVenous Administration / US Food and Drug Administration / Oxford University Institute of Musculoskeletal Sciences / University of Southampton / 4The Mellanby Centre for Bone Research / /
Person
Michael Pazianas / Hal Ebetino / Graham G Russell / / /